EAACI-GA²LEN-EDF-WAO – Guideline on urticaria
| 27. | Zuberbier, T. and Maurer, M.: EAACI-GA²LEN-EDF-WAO – Guideline on urticaria. In: Akdis, C. A. and Agache, I., editors: Global atlas of allergy. EAACI, 2014 |
Results
Found 544 hits.
Search Results for: L3M2 Studienmaterialien: Ethical Procurement and Supply - L3M2 Torrent Prüfung - L3M2 wirkliche Prüfung 🍱 Suchen Sie auf （ www.itzert.com ） nach 《 L3M2 》 und erhalten Sie den kostenlosen Download mühelos 🙁L3M2 Prüfungs-Guide – Page 8
The characteristics and impact of pruritus in in adult dermatologic patients: a prospective, cross-sectional study
| 428. | Hawro, T., Prybyłowicz, K., Spindler, M., Hawro, M., Steć, M., Altrichter, S., Weller, K., Magerl, M., Reidel, U., Alarbeed, E., Alraboni, O., Maurer, M.+, and Metz, M.: The characteristics and impact of pruritus in in adult dermatologic patients: a prospective, cross-sectional study. J. Am. Acad. Dermatol. 2021: 84; 691-700. IF: 15.49 |
o.428
High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: A randomized, placebo-controlled, crossover study
| 70 | Siebenhaar, F., Degener, F., Zuberbier, T., Martus, P., and Maurer, M.+: High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J. Allergy Clin. Immunol. 2009: 123; 672-679. IF: 9.16 |
Who is really in control of skin immunity under physiological circumstances – lymphocytes, dendritic cells or keratinocytes?
| 14. | Schröder, J. M., Reich, K., Kabashima, K., Liu, F. T., Romani, N., Metz, M., Kerstan, A., Lee, P. H. A., Loser, K., Schön, M. P., Maurer, M., Stoitzner, P., Beissert, S., Tokura, Y., and Gallo, R. L.: Who is really in control of skin immunity under physiological circumstances – lymphocytes, dendritic cells or keratinocytes? Exp. Dermatol. 2006: 15; 913-929. IF: 2.45 |
Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey
| 340 | Maurer, M.+, Bork, K., Martinez-Saguer, I., Aygören-Pürsün, E., Botha, J., Andresen, I., and Magerl, M.: Management of patients with hereditary angioedema in Germany: comparison to other countries in the icatibant outcome survey. J. Eur. Acad. Dermatol. Venereol. 2019: 33; 163-169. IF: TBD (IF 2018: 5.11) |
A review of international recommendations for the diagnosis and management of chronic urticaria
| 118. | Beck, L. A., Bernstein, J. A., and Maurer, M.: A review of international recommendations for the diagnosis and management of chronic urticaria. Acta Derm. Venereol. 2017: 97; 149-158. IF: 3.13 |
r.118
Cryopyrin-assoziierte periodische Syndrome
| 57. | Krause, K., Feist, E., Maurer, M., and Kallinich, T.: Cryopyrin-assoziierte periodische Syndrome (CAPS) – Prototypen autoinflammatorischer Erkrankungen. ZfKuJM 2011: 6; 349-357. IF: N/A |
r.057
In urticarial vasculitis, long disease duration, high symptom burden, and high need for therapy are linked to low patient-reported quality of life
|
505. |
Bonnekoh, H., Jelden-Thurm, J., Butze, M., Krause, K., Maurer, M., and Kolkhir, P.+: In urticarial vasculitis, long disease duration, high symptom burden, and high need for therapy are linked to low patient-reported quality of life. J. Allergy Clin. Immunol. Pract. 2022: 10; 2734-2741. IF: 9.40 |
o.505